Quick Answer
LakeShore Biopharma Co., Ltd. reported Diluted EPS of $5.22 per share (loss) for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$5.22 | +87.1% |
| 2024 | -$40.54 | -72.1% |
| 2023 | -$23.55 | -1277.2% |
| 2022 | -$1.71 | +44.8% |
| 2021 | -$3.10 | — |
- LakeShore Biopharma Co., Ltd. showed an increase of +87.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, LakeShore Biopharma Co., Ltd.’s diluted eps has declined by 68.4% (from $3.10 per share (loss) to $5.22 per share (loss)).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: